Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Pharmaceuticals Other
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| AMRN | Amarin Corporation Plc Sponsored ADR | 1.68% | 17.52 | 2.0% | $170.25m | |
| SAGE | SAGE Therapeutics, Inc. | -1.79% | 137.29 | 9.5% | $121.17m | |
| PRGO | Perrigo Co. Plc | -2.26% | 44.93 | 6.8% | $100.11m | |
| JAZZ | Jazz Pharmaceuticals Plc | -0.32% | 128.66 | 2.2% | $87.44m | |
| GWPH | GW Pharmaceuticals PLC Sponsored ADR | 1.44% | 139.26 | 6.3% | $78.73m | |
| PTLA | Portola Pharmaceuticals, Inc. | -3.77% | 25.53 | 7.7% | $54.93m | |
| ICPT | Intercept Pharmaceuticals, Inc. | -2.22% | 110.93 | 18.6% | $52.57m | |
| AXSM | Axsome Therapeutics, Inc. | 4.41% | 8.52 | 2.7% | $46.12m | |
| MNK | Mallinckrodt Plc | -3.15% | 19.98 | 21.1% | $40.05m | |
| CTLT | Catalent Inc | -0.62% | 35.39 | 2.4% | $39.43m | |
| ICLR | ICON Plc | -0.68% | 132.28 | 4.1% | $38.89m | |
| UTHR | United Therapeutics Corporation | -1.60% | 113.90 | 14.4% | $34.98m | |
| ENDP | Endo International Plc | -4.23% | 9.29 | 8.9% | $32.66m | |
| HZNP | Horizon Pharma plc | 0.37% | 21.92 | 7.4% | $26.48m | |
| PCRX | Pacira Pharmaceuticals, Inc. | 1.05% | 40.46 | 10.6% | $25.36m |
Company Profile
SCYNEXIS, Inc. engages in the development and commercialization of novel anti-infectives, which addresses the significant unmet therapeutic needs. It develops a novel oral and intravenous drug for several fungal infections, including serious and life-threatening invasive fungal infections. The company was founded by Scot Kevin Huber, Terry Eugene Marquardt, Pierre Bernard Jacques Monnet, Russell J. Outcalt, and Yves Joseph Ribeill on November 4, 1999 and is headquartered in Jersey City, NJ.